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Abstract We describe a hitherto undocumented variant
of dimorphic pituitary neoplasm composed of an
admixture of neurosecretory cells and profuse leiomyo-
matous stroma around intratumoral vessels. Radiologi-
cally perceived as a macroadenoma of 3.8 cm in
diameter, this pituitary mass developed in an otherwise
healthy 43-year-old female. At the term of a yearlong
history of amenorrhea and progressive bitemporal visual
loss, subtotal resection was performed via transsphe-
noidal microsurgery. Discounting mild hyperprolactin-
emia, there was no evidence of excess hormone
production. Histologically, solid sheets, nests and cords
of epithelial-looking, yet cytokeratin-negative cells were
seen growing in a richly vascularized stroma of spindle
cells. While strong immunoreactivity for NCAM, Syn-
aptophysin and Chromogranin-A was detected in the
former, the latter showed both morphological and
immunophenotypic hallmarks of smooth muscle, being
positive for vimentin, muscle actin and smooth muscle
actin. Architectural patterns varied from monomor-
phous stroma-dominant zones through biphasic neuro-
endocrine-leiomyomatous areas, to pseudopapillary
fronds along vascular cores. Only endothelia were la-
beled with CD34. Staining for S100 protein and GFAP,
characteristics of sustentacular cells, as well as bcl-2 and
c-kit was absent. Except for a-subunit, anterior pituitary
hormones tested negative in tumor cells, as did a panel
of peripheral endocrine markers, including serotonin,
somatostatin, calcitonin, parathormone and vasoactive
intestinal polypeptide. Mitotic activity was absent and
the MIB-1 labeling index low (1–2%). While assignment
of this lesion to any established neoplastic entity is not
forthcoming, we propose it is being considered as a low-
grade neuroendocrine tumor possibly related to null cell
adenoma.
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Introduction
The variety of neoplasms and pseudotumoral entities
encountered in and around the sella turcica reﬂects both
the anatomical complexity of the skull base and the
versatile functions of the pituitary proper [1, 4, 12, 19].
The majority of sellar mass lesions with endocrine
phenotype are adenomas or hyperplasias originating
from adenohypophyseal epithelial cells [4]. Very rarely,
neuroepithelial (gangliocytic) elements of adenomatous
tissue may participate, a constellation referred to as
PANCH (pituitary adenoma with neuronal choristoma)
[11]. In addition, sporadic examples of sellar paragan-
glioma, a neurosecretory tumor of the dispersed neuro-
endocrine system, are on record [15, 22, 24, 26, 28]. In
either case, a handful of appropriately selected immu-
nohistochemical markers, especially low molecular
weight cytokeratin and synaptophysin as well as staining
for pituitary hormones, usually allow for such processes
to be assigned one of major, well-deﬁned nosological
categories [4].
In the following, we would like to share our experi-
ence with an intriguing biphasic neoplasm composed of
cytokeratin-negative endocrine cells and prominent
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fusiform stroma with leiomyoma-like immunoreactivity.
While comparable to either null cell adenoma or para-
ganglioma with respect to its neurosecretory element,
the stromal moiety of this lesion oﬀers a pattern not
previously documented in such tumors. On the other
hand, no analogy is forthcoming to recently deﬁned
spindle-cell neoplasms (pituicytoma, spindle-cell onco-
cytoma) of purported astrocytic or folliculostellate cell
derivation either [3, 21].
Case report
Clinical history and imaging
The patient, a 43-year-old female, ﬁrst consulted the
Department of Endocrinology of the University Hospi-
tal Bern 2 years ago, reporting secondary amenorrhea
and spontaneous galactorrhea. Except for mild arterial
hypertension, anamnestic exploration was noncontrib-
utory. In particular, there was no evidence of extracra-
nial malignant disease or a family history of
phakomatosis or multiple endocrine neoplasia (MEN)
syndrome. Laboratory testing revealed hyperprolactin-
emia of 120 lg/l, as well as secondary hypogonadism.
Cranial magnetic resonance imaging (MRI) conﬁrmed
the presence of a sellar space occupying lesion of
3·3·1.5 cm, compatible with nonfunctioning pituitary
macroadenoma. The patient then declined surgery and
was administered oral dopaminergic medication with
Cabergoline (Dostinex).
While this achieved relief of endocrine symptoms,
perimetric assessment revealed gradual bitemporal vi-
sual ﬁeld loss, indicating enlargement of the tumor at 1-
year interval. On preoperative MRI, the lesion measured
3.8·3.2·2.4 cm, with para- and suprasellar extension
(Fig. 1). Subtotal extirpation was performed via trans-
sphenoidal approach. During surgery, the tumor was
seen eroding the sphenoid bone and inﬁltrating both
cavernous sinuses. Extensive adhesions to the optic
chiasm prevented complete removal of the suprasellar
part of the tumor. Postoperative recovery was unevent-
ful, and no adjuvant radiotherapy administered.
Materials and methods
The surgical specimen, comprising several grayish white
tissue fragments of a total volume of 1.5 mm3, was ﬁxed
in 4% buﬀered formalin, processed in paraﬃn and
serially sectioned to 4 lm thick slides. Histochemical
stains included hematoxylin and eosin (H.E.), periodic
acid-Schiﬀ (PAS), van Gieson’s elastic stain (EvG),
Grimelius’ chromaﬃn method and Gomori’s reticulin
(Ag).
For immunohistochemistry, dewaxed sections were
pretreated either by boiling in 10 mM citrate buﬀer (pH
6.0) or 10 mM Tris–1 mM EDTA (pH 9.0) or by partial
enzymatic digestion with 1 mg/ml trypsin 1:250 (Difco,
Detroit, MI, USA). The sections were then (and fol-
lowing all subsequent steps) washed in Tris-buﬀered
saline (TBS) and incubated with the primary antibody
diluted in TBS with 0.5% casein and 5% normal goat
serum, for 60 min at room temperature. The procedures
for antigen retrieval and speciﬁcation of primary anti-
bodies are summarized in Table 1. Next, either a 1:300
dilution of biotinylated goat-anti-mouse immunoglobu-
lin (Ig) or a 1:500 dilution of biotinylated goat-anti-
rabbit Ig antiserum (depending on the species in which
the primary antibody had been raised) was applied for
45 min. Thereafter sections were incubated with strep-
tavidin–biotin complex/alkaline phosphatase (1:200 in
TBS) (DakoCytomation) for 45 min. Finally, sections
were developed with new fuchsin-naphtol AS-BI as
chromogen (Sigma, St. Louis MO, USA) for 30 min,
counterstained with hematoxylin and mounted.
Fig. 1 Imaging characteristics of LANT. T1 weighted frontal MRI
scan (a) to show isointense pituitary tumor with suprasellar
extension and partial encirclement of carotid arteries. On post-
contrast frontal and sagittal sequences (b, c) there is marked
homogenous enhancement of gadolinium. Inﬁltration of cavernous
sinuses (b) and compression of chiasmatic cistern (c) are evident
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Pathological ﬁndings
Microscopical examination showed a moderately cellu-
lar biphasic tumor, characterized by alternate epithelial-
like cuboidal cells and fascicles of spindly stroma. The
former tended to aggregate in solid sheets within slit-like
spaces, often with nuclear crowding and peripheral
shrinkage artifacts (Fig. 2a). Scattered nests of clear cells
reminiscent of ‘‘Zellballen’’—some of them conﬁned
within argyrophilic acini—were occasionally seen, while
true paragangliomatous ribbons were absent. In be-
tween, stromal cells displayed bipolar cytoplasmic
extensions individually ensheathed by basal lamina. Ci-
gar-shaped nuclei were remarkably monomorphous and
tended to lie centrally on cross-section proﬁles. The tu-
mor was richly vascularized throughout, with cushions
of stromal cells seemingly ‘‘budding’’ from adventitia
(Fig. 2j, k). There were irregular transitions from com-
pact stroma-predominant ﬁelds to papillary projections
lined by a ﬂattened layer of epithelial-like cells (Fig. 2b,
c). Cellular atypia was absent in both components, as
was signiﬁcant mitotic activity; neither were there in-
tratumoral regressive changes (necrosis).
On immunohistochemistry, the epithelial-like popu-
lation displayed a rudimentary neurosecretory pheno-
type (Fig. 2/d–f, l), being strongly reactive for neural cell
adhesion molecule (NCAM—CD56), synaptophysin
and chromogranin-A and negative for neuroﬁlament
protein, epithelial membrane antigen (EMA) and cyto-
keratins, including the low molecular species cytokeratin
8 (CAM5.2). Except for a-subunit, all major anterior
pituitary hormones tested negative, as did a panel of
peripheral endocrine markers (Fig. 2g). Most stromal
cells were labeled with antibodies to vimentin and
smooth muscle actin, with a signiﬁcant proportion
reacting for muscle actin as well (Fig. 2i, k). Staining for
collagen type IV highlighted pericellular basal lamina.
While endothelia consistently expressed CD34, only a
small subset of stromal elements showed such positivity
(Fig. 2h). Likewise, S100 protein immunoreactive cells,
especially ones of sustentacular conﬁguration, were ab-
sent. Reactions for bcl-2 and c-kit yielded negative re-
sults. No staining for the melanosomal marker HMB45
was detected. Occasional positive nuclei in both neuro-
secretory and stromal components randomly added up
to a MIB-1 count of less than 2%.
Table 1 Overview of primary antibodies for immunohistochemistry and antigen retrieval methods
Antigen targeted Clone Sourcea Antibody
concentrationb
Pretreatment
PanCytokeratin MNF116 DakoCytomation 3.4 lg/ml Trypsin
Cytokeratin 8 CAM 5.2 BD Biosciences 1.3 lg/ml Trypsin
EMA E29 DakoCytomation 2.4 lg/ml Microwave: citrate
Synaptophysin Snp88 BioGenex 1:100 Pressure cooker: citrate
Chromogranin Polyclonal DakoCytomation 1:300 Microwave: citrate
NCAM 123C3 Monosan 1:30 Pressure cooker: citrate
NF 2F11 DakoCytomation 5.4 lg/ml Pressure cooker: citrate
S100 protein Polyclonal DakoCytomation 1:800 Trypsin
Vimentin Vim 3B4 DakoCytomation 0.5 lg/ml Trypsin
GFAP 6F2 DakoCytomation 2.5 lg/ml Microwave: citrate
CD34 QBend/10 DakoCytomation 0.8 lg/ml Pressure cooker: citrate
Actin HHF35 DakoCytomation 1.1 lg/ml Trypsin
SMA 1A4 Sigma 10.8 lg/ml No pretreatment
Desmin D33 DakoCytomation 4.6 lg/ml Pressure cooker: citrate
c-kit (CD117) Polyclonal DakoCytomation 1:300 Microwave: EDTA
HMB45 HMB45 DakoCytomation 1.6 lg/ml Microwave: citrate
Ki-67 MIB-1 DakoCytomation 1.6 lg/ml Pressure cooker: citrate
ACTH 02A3 DakoCytomation 0.8 lg/ml No pretreatment
PRL Polyclonal DakoCytomation 1:300 Microwave: citrate
GH Polyclonal DakoCytomation 1:400 No pretreatment
TSH 0042 DakoCytomation 0.4 lg/ml Pressure cooker: citrate
FSH C10 DakoCytomation 0.6 lg/ml Trypsin
LH C93 DakoCytomation 0.5 lg/ml Pressure cooker: citrate
a-SU F3458 Sera-Lab 2.0 lg/ml No pretreatment
VIP Polyclonal Chemicon 1:600 Microwave: citrate
Somatostatin Polyclonal DakoCytomation 1:1,000 Pressure cooker: citrate
Calcitonin Polyclonal DakoCytomation 1:200 Trypsin
Parathormone 3B3 DakoCytomation 1.3 lg/ml Pressure cooker: citrate
Serotonin 5HT-H209 DakoCytomation 11.2 lg/ml Trypsin
Insulin K36aC10 Sigma 1:1,000 Trypsin
Collagen IV 8C5 5A5 Dianova 1:40 Microwave: citrate
aDakoCytomation, Glostrup, Denmark; BD Biosciences, San Jose, CA, USA; BioGenex, San Ramon, CA, USA; Chemicon, Temecula,
CA, USA; Dianova, Hamburg, Germany; Monosan, Uden, The Netherlands; Sera-Lab, Sussex, UK; Sigma, St. Louis, MO, USA




We describe a clinically nonfunctioning, low-grade, in-
trasellar neoplasm with biphasic composition, including
neuroendocrine cells and leiomyomatous stroma. While
metastatic origin could conﬁdently be excluded on both
clinical grounds and absence of any intrinsic sign of
malignancy, the unique features of this neoplasm did not
ﬁt into any established neoplastic category indigenous to
the sella either.
Albeit morphologically versatile, over 90% of pitui-
tary adenomas, including those rare examples with
neuronal metaplasia, consistently express cytokeratins,
especially cytokeratin 8 [4]. While angiomatous vessels
may occur in macroadenomas prone to apoplexy, these
tend to be ectatic and thin-walled, rather than of an-
gioleiomyomatous type. Conversely, spindle-cell pitui-
tary lesions, i.e. granular cell tumor, as well as the
recently introduced pituicytoma and spindle-cell onco-
cytoma, are monophasic in composition and lack evi-
dence of neurosecretion [4]. Be they of purported
Schwannian, astrocytic or folliculostellate cell descent,
these uncommon neoplasms are labeled with antibodies
to S100 protein and/or GFAP, staining for which was
entirely absent in our case [3, 21].
By virtue of it incorporating microvascular sphincter-
like structures reminiscent of gomitoli bodies of the
pituitary stalk, the present tumor further raised the
diﬀerential diagnosis of glomangioma. However, akin to
acral glomangiomas, those exceptional intrasellar
occurrences on record reﬂect pericytic rather than neu-
roectodermal derivation of tumor cells [2, 8, 9]. We
could identify a single case report of intrasellar leiomy-
oma [13]. Published prior to the routine use of immu-
nohistochemistry, the ﬁgures accompanying that paper
nevertheless depict an otherwise unremarkable, pure
spindle-cell tumor.
A remote similarity to perivascular myomelanocytic
tumor (PEComa) prompted us to perform immunohis-
tochemistry for HMB45, which resulted negative [14].
When its prominent neuroendocrine features are gi-
ven consideration, this tumor is further suggestive of
paraganglioma [15, 18, 22, 24, 26, 28]. Indeed, detection
of synaptophysin and/or chromogranin-A has com-
monly been relied on to identify both these neoplasms of
the dispersed neuroendocrine system and pituitary ade-
nomas [4, 23]. Only a minority of extraadrenal para-
gangliomas are functioning, with catecholamines,
serotonin and vasoactive intestinal polypeptide (VIP)
being the most frequent secretory products. While
commonly encountered in gonadotroph cell adenomas
and the so-called null cell adenomas, immunoreactivity
for a-subunit, as seen in our case, may exceptionally
occur in paragangliomas as well [4, 5]. Not only are
primary intrasellar paragangliomas exceedingly rare but
also we are unable to identify any previous bona ﬁde
example with mixed neurosecretory-leiomyomatous
pattern, irrespective of location.
The rather speculative issue of a solitary ﬁbrous tu-
mor (SFT) colliding with or an inﬂammatory pseudo-
tumor permeating the stroma of a null cell adenoma or
paraganglioma was excluded by the absence of CD34
immunoreactivity in most spindle cells other than
endothelia [1, 6]. An extensive search of the literature
yielded a single reference to a case of vaginal leiomyoma
with intratumoral paraganglion cells [17]. While these
likely originated from intramural paraganglia, possibly
with secondary hyperplasia, no such structures are
normally present in the pituitary.
Developmental remnants of the neural crest at the skull
base are considered the most likely source of intrasellar
paragangliomas [22]. Horvath et al. [11] discussed ‘‘line-
age inﬁdelity’’ of adenohypophyseal epithelium to ac-
count for the occurrence of hybrid adenomatous-
neuronal (gangliocytic) pituitary tumors. In a similar vein,
folliculostellate cells have been considered as a possible
neoplastic reservoir with stem cell properties [21]. Though
such dysontogenetic conceptsmay be all accommodating,
the actual morphogenesis of stromal spindle cells in our
case remains speculative. These may, for instance, repre-
sent but a variant of otherwise well-known ﬂorid micro-
vascular proliferation in endocrine neoplasia, with
grotesque overgrowth of adventitial smoothmuscle [7, 16,
25]. Conversely, neuroepithelial tumor cells may have
undergone myogenic metaplasia. A similar phenomenon
has been known to occur in some tumors of the nervous
system of both glial and neural crest derivation—includ-
ing benign lesions [27]. Along the same line, an origin from
pluripotential neural crest cells with dual stromal/neuro-
secretory commitment is also plausible. A neoplastic
phenotype of this kind has indeed been documented in
gastrointestinal stromal tumors (GISTs) of the Carney
triad [10, 20]. Conspicuously, aﬀected individuals tend to
develop paragangliomas aswell. At variance fromGISTs,
however, spindle cells in the present case failed to react for
c-kit, and the patient did not present any clinical evidence
of the Carney triad either.
We interpret our ﬁndings as a peculiar form of
low-grade, dimorphic neuroendocrine neoplasm with
Fig. 2 Histology and immunophenotype of LANT. Biphasic
architecture composed of solid nests of nondescript neuroendocrine
cells with intervening bundles of fusiform stroma (a). Architectural
patterns include transitions from hypocellular stroma-dominant
zones (b) to papillary projections (c). Immunohistochemical
detection of synaptophysin (d–f) indicates neuroendocrine pheno-
type of tumor cells. Diﬀerent staining patterns are appreciated on
corresponding sections from mixed neuroendocrine/mesenchymal
(a, d), stroma-dominant (b, e) and papillary (c, f) areas. Only
positivity for a-subunit (g) suggests possible adenohypophyseal
origin of tumor cells. Endothelia of intratumoral blood vessels are
labeled with CD34 (h), while intervening spindle cells are negative.
Most of the latter show intense staining for smooth muscle actin on
adjacent section plane (i). Organoid association of intratumoral
arterioles and perivascular layers of smooth muscle cells (j)
reminiscent of microvascular sphincter. Circumscribed ‘‘bud-like’’
compactions of stromal cells (k, l, arrows) were often felt to result
from such perivascular structures. Microphotographs not other-
wise labeled represent H.E. stains. Except for ‘‘j’’ (40 lm), bars
correspond to 20 lm
b
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prominent stromal component. Being cytokeratin neg-
ative and showing only a rudimentary secretory pheno-
type, the epithelial-looking component may not allow
for deﬁnite histogenetic classiﬁcation into adenohy-
pophyseal or neuroepithelial in nature. The descriptive
diagnosis ‘‘leiomyomatoid angiomatous neuroendocrine
tumor’’ (LANT) is therefore proposed to address both
the conspicuous stroma and the noncommittal mor-
phology of the secretory element of the tumor. This
serendipitous observation awaits conﬁrmation by addi-
tional reports.
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